After ANDA approval
Glenmark Generics, an USA based subsidiary has been granted by United States Food and Drug Administration (USFDA) final abbreviated new drug approval (ANDA) for its Escopizlone tablets used for treatment of insomnia.Powered by Capital Market - Live News
